In an ordinal analysis of the modified Rankin scale score at 90 days, patients in the tenecteplase group had a median score of 2 (interquartile range, 0 to 3), which indicated significantly better ...

The session focused on the evolution of stroke care, particularly ischemic strokes, which make up 87% of all strokes. It ...

Analysis of categorized scores on the modified Rankin scale confirmed the lack of benefit: the odds ratio for trichotomization into modified Rankin scale scores of 0 to 1 versus 2 to 3 versus 4 to ...

Researchers found that the percentage of patients achieving a score of 0 or 1 on the modified Rankin scale at 90 days was 40.3 and 26.3% in the alteplase and standard medical treatment groups ...

Delirium affected 44% of critically ill patients in an Ohio medical center who were hospitalized after a recent stroke, ...

Modified Rankin Scale (mRS): This assesses a person’s level of disability after a stroke. It evaluates six different levels of disability, which include: 0: There are no symptoms.

The primary endpoint was a predefined clinical outcome based on the proportion of patients who achieved a modified Rankin Scale score of 0-1 at 90 to 120 days, as assessed by the Rankin Focused ...

Results. Compared to healthy subjects, patients with ischemic stroke, especially those with a modified Rankin scale ≥ 4, had impaired GMA in both fasting and postprandial states.

Stroke survivors were 44% more likely to have an excellent outcome (modified Rankin score 0-1) after 90 days if they received the tenecteplase injection and standard care after clot removal ...

Their first-in-human clinical trial, which spanned 12 months, included 18 adults who were 6 to 60 months post-ischemic subcortical middle cerebral arterial stroke and recorded a Modified Rankin ...